Aspire Biopharma Hldgs Inc.
13F holders, Q3 2025 (September 30)25holders +9
12new positions
3sold out
$0.21avg. 13F price*
At the end of Q3 2025, 25 institutions reported holding Aspire Biopharma Hldgs Inc. in their 13F filings, up 9 from Q2 2025. 12 opened new positions and 3 sold out. The largest holders were Crewe Advisors LLC ($168K), Procyon Advisors, LLC ($97K) and Vanguard Group Inc. ($88K).
- Company
- Aspire Biopharma Hldgs Inc.
- CUSIP
- 738920107
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q2 2025 → Q3 2025
| Institutions | Total Value | |
|---|---|---|
| New Positions | 12 | $246K |
| Exits | 3 | $10K |
All 13F filers, Q2 2025 → Q3 2025: 1,440,517 shares bought and 361,778 shares sold, net +1,078,739 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 25 holders
| Crewe Advisors LLC | 0.02% | Add +29.8% | 813,427 | $168K |
| Procyon Advisors, LLC | 0.01% | Reduce -27.1% | 472,661 | $97K |
| Vanguard Group Inc. | 0.00% | New | 428,552 | $88K |
| Optivise Advisory Services LLC | 0.03% | Add +12.1% | 263,522 | $54K |
| Geode Capital Management, LLC | 0.00% | New | 250,161 | $52K |
| Antara Capital LP | 8.64% | New | 202,897 | $42K |
| VR Advisory Services Ltd | 0.00% | No change | 97,391 | $20K |
| Resolute Advisors LLC | 0.00% | New | 82,783 | $17K |
| Three Seasons Wealth, LLC | 0.00% | No change | 75,000 | $15K |
| P Schoenfeld Asset Management LP | 0.00% | New | 58,563 | $12K |
| Avion Wealth | 0.00% | New | 54,113 | $11K |
| Periscope Capital Inc. | 0.00% | Reduce -33.3% | 50,000 | $10K |
| CIBC Private Wealth Group LLC | 0.00% | Add +591.2% | 49,129 | $10K |
| Valley Wealth Managers, Inc. | 0.00% | No change | 40,000 | $8K |
| Platform Technology Partners | 0.00% | No change | 37,611 | $8K |
| Crossingbridge Advisors, LLC | 0.01% | New | 24,348 | $7K |
| Tower Research Capital LLC (TRC) | 0.00% | New | 31,120 | $6K |
| Jane Street Group, LLC | 0.00% | Reduce -80.8% | 29,257 | $6K |
| XTX Topco Ltd | 0.00% | New | 27,851 | $6K |
| Focus Partners Wealth | 0.00% | New | 12,538 | $3K |
| Allred Capital Management, LLC | 0.00% | No change | 11,185 | $2K |
| UBS Group AG | 0.00% | New | 7,661 | $2K |
| SOA Wealth Advisors, LLC. | 0.00% | New | 2,920 | $602 |
| Bank of America Corp. | 0.00% | Reduce -6.6% | 253 | $52 |
| Osaic Holdings, Inc. | 0.00% | No change | 100 | $20 |
"% of holder's portfolio" is ASPIRE BIOPHARMA HLDGS INC's weight in each manager's 13F, not the share of Aspire Biopharma Hldgs Inc. the manager owns.